Research Programmes

MCC-Spain

Population based multicasecontrol study on common tumours in Spain

Coordinator
Manolis Kogevinas
Funded by
CIBERESP, FIS
Website
http://www.mccspain.org/

The MCC-Spain study, conducted within the Spanish Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), is a unique initiative to evaluate etiological factors for common cancers and will promote cancer research and prevention in Spain.

In 2008, the CIBERESP, within the framework of Cross-Sectional Action in Cancer, provided the resources to launch a population-based multicase-control study (MCC-SPAIN) in order to research the influence of environmental factors and their interaction with genetic factors in frequent tumours or tumours with peculiar epidemiological characteristics in our country, in which the environmental factors involved are not sufficiently understood.

The selected tumours are colorectal cancer, breast cancer, gastroesophageal cancer and prostate cancer. Chronic lymphocytic leukaemia (CLL) has been recently added to the study. Colorectal cancer has been selected due to its frequency in both sexes. Gastroesophageal cancer has been selected due to its characteristic geographic pattern and the environmental hypotheses suggested. Prostate cancer has been chosen due to its frequency and its hormonal nature, sharing with breast cancer the etiological hypotheses of endocrine disruption. The study involves data collection using an interview as well as the obtention of several biological samples. The population controls have been selected from primary care centre lists and interviews are performed in these centres.

The MCC-Spain study is coordinated by Manolis Kogevinas (ISGlobal) and Marina Pollan (ISCIII). Researchers from the CIBERESP in 11 autonomous communities of Spain (Catalonia, Madrid, Asturias, Navarra, Basque Country, Murcia, Cantabria, Andalusia, Valencia, Castilla y Leon) are participating in the study. Up until March 2010 information and biologic samples were obtained from 1,600 population controls, 1,200 colon and rectum cases, 750 breast cancer cases, 450 prostate cancer cases, 120 stomach cancer cases, and the collection of leukaemia cases was initiated.

Our Team

Principal Investigator (PI)

  • Emmanouil Kogevinas
    Emmanouil Kogevinas

Our Team

See More

Other projects

See Past Projects

PROactive

Physical Activity as a Crucial Patient Reported Outcome in COPD

OMEGA-NET

Network on the Coordination and Harmonisation of European Occupational Cohorts

POLLAR

Impact Of Pollution on Asthma and Rhinitis

EPHOR

Exposome Project for Health and Occupational Research

CORSAIR

Severe respiratory failure in COVID-19: clinical, biological and imaging risk factors

VEIS

Leveraging the European Genome-Phenome Archive (EGA) for Industry and Society

Mobilise-D

Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement

COVICAT

Cohorte Covid-19 en Cataluña

EARLY-ADAPT

Signs of Early Adaptation to Climate Change

AiguaBCN

Exposure to emerging contaminants in drinking water in Barcelona potentially liked to chronic diseases and wellbeing

Fotovoz

Las Voces de los Afectados por la Nefropatía Mesoamericana

CALMA

Co-created educational programme for dyspnea-bearing patients and their caregivers

Cancer-Watch

Risk of colorectal and breast cancer with widespread drinking water chemical contaminants

CONTENT

Cohort of COVID-19 in Spain: social dynamics, mental health and inequalities

EXPANSE

EXposome Powered tools for healthy living in urbAN SEttings

COVAIR-CAT

Air Pollution in Relation to COVID-19 Morbidity and Mortality: A Large Population-Based Cohort Study in Catalonia

iGenCO

In-Depth Genomics and Cross-Omics Analysis for Undiagnosed Rare Diseases on a User-Friendly Collaborative Platform